Vascular Biogenics Ltd (VBLT)

[Oren1976]

The market will understand after the big huge success of the phase 3 in rgbm that vb111 as monotherapy is a life changer in cancer. The phase 3 won't be just a success it will be a big success. The reason is that in the phase 2 they took patients without choosing. The phase 3 they choose more and it also looks like from what I read in forums that doctor recommend patients who didn't react with fever to withdraw from trial this actually helps the treatment arm. You will see higher response rate in this phase 3. Trust dror and his friend doctors. The reason they are doing it is because all neuro and doctor community think this drug should be on the shelf. The results from phase 3 will surprise everybody except me